Mesenchymal Stromal Cells Fail to Prevent Acute Graft-versus-Host Disease and Graft Rejection after Dog Leukocyte Antigen-Haploidentical Bone Marrow Transplantation

Bartholomew, 2002, Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo, Exp Hematol, 30, 42, 10.1016/S0301-472X(01)00769-X Le Blanc, 2003, Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex, Scand J Immunol, 57, 11, 10.1046/j.1365-3083.2003.01176.x Krampera, 2003, Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide, Blood, 101, 3722, 10.1182/blood-2002-07-2104 Sudres, 2006, Bone marrow mesenchymal stem cells suppress lymphocyte proliferation in vitro but fail to prevent graft-versus-host disease in mice, J Immunol, 176, 7761, 10.4049/jimmunol.176.12.7761 Chung, 2004, Cotransplantation of marrow stromal cells may prevent lethal graft-versus-host disease in major histocompatibility complex–mismatched murine hematopoietic stem cell transplantation, Int J Hematol, 80, 370, 10.1532/IJH97.A30409 Tisato, 2007, Mesenchymal stem cells of cord blood origin are effective at preventing but not treating graft-versus-host disease, Leukemia, 21, 1992, 10.1038/sj.leu.2404847 Lazarus, 2005, Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients, Biol Blood Marrow Transplant, 11, 389, 10.1016/j.bbmt.2005.02.001 in’t Anker, 2003, Nonexpanded primary lung and bone marrow–derived mesenchymal cells promote the engraftment of umbilical cord blood-derived CD34(+) cells in NOD/SCID mice, Exp Hematol, 31, 881, 10.1016/S0301-472X(03)00202-9 Angelopoulou, 2003, Cotransplantation of human mesenchymal stem cells enhances human myelopoiesis and megakaryocytopoiesis in NOD/SCID mice, Exp Hematol, 31, 413, 10.1016/S0301-472X(03)00042-0 Le Blanc, 2007, Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells, Leukemia, 21, 1733, 10.1038/sj.leu.2404777 Lee, 2002, Br J Haematol, 118, 1128, 10.1046/j.1365-2141.2002.03767.x Lee, 2010, Canine bone marrow-derived mesenchymal stromal cells suppress allo-reactive lymphocyte proliferation in vitro but fail to enhance engraftment in canine bone marrow transplantation, Biology of Blood and Marrow Transplantation Le Blanc, 2004, Treatment of severe acute graft-versus-host disease with third-party haploidentical mesenchymal stem cells, Lancet, 363, 1439, 10.1016/S0140-6736(04)16104-7 Lazarus, 1995, Ex vivo expansion and subsequent infusion of human bone marrow–derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use, Bone Marrow Transplant, 16, 557 Koc, 2000, Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy, J Clin Oncol, 18, 307, 10.1200/JCO.2000.18.2.307 Ringdén, 2006, Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease, Transplantation, 81, 1390, 10.1097/01.tp.0000214462.63943.14 Le Blanc, 2008, Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study, Lancet, 371, 1579, 10.1016/S0140-6736(08)60690-X Baron, 2010, Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning, Biol Blood Marrow Transplant, 16, 838, 10.1016/j.bbmt.2010.01.011 Martin, 2010, Prochymal improves response rates in patioents with steroid-refractory acute graft versus host disease (SR-GVHD) involving the liver and gut: results of a randomized, placebo-controlled, multicenter phase III trial in GVHD, Biol Blood Marrow Transplant, 16, 41 Roecklein, 1995, Functionally distinct human marrow stromal cell lines immortalized by transduction with the human papilloma virus E6/E7 genes, Blood, 85, 997, 10.1182/blood.V85.4.997.bloodjournal854997 Graf, 2002, Gene expression profiling of the functionally distinct human bone marrow stromal cell lines HS-5 and HS-27a, Blood, 100, 1509, 10.1182/blood-2002-03-0844 Gartner, 1980, Long-term culture of human bone marrow cells, Proc Natl Acad Sci U S A, 77, 4756, 10.1073/pnas.77.8.4756 Raff, 1985, Recognition of target cell determinants associated with DLA-D locus–encoded antigens by canine cytotoxic lymphocytes, Transplantation, 40, 323, 10.1097/00007890-198509000-00020 Burroughs, 2005, Durable engraftment of AMD3100-mobilized autologous and allogeneic peripheral blood mononuclear cells in a canine transplantation model, Blood, 106, 4002, 10.1182/blood-2005-05-1937 Wagner, 1996, Histocompatibility testing of dog families with highly polymorphic microsatellite markers, Transplantation, 62, 876, 10.1097/00007890-199609270-00032 Wagner, 1998, DLA-DRB1 and DLA-DQB1 histocompatibility typing by PCR-SSCP and sequencing, Tissue Antigens, 52, 397, 10.1111/j.1399-0039.1998.tb03063.x Mielcarek, 1996, CD14+ cells in granulocyte colony-stimulating factor (G-CSF)-mobilized peripheral blood mononuclear cells induce secretion of interleukin-6 and G-CSF by marrow stroma, Blood, 87, 574, 10.1182/blood.V87.2.574.bloodjournal872574 Mielcarek, 2006, Denileukin difitoxin as prophylaxis against graft-versus-host disease in the canine hematopoietic cell transplantation model, Biol Blood Marrow Transplant, 12, 899, 10.1016/j.bbmt.2006.05.005 Georges, 2001, Engraftment of DLA-haploidentical marrow with ex vivo expanded, retrovirally transduced cytotoxic T lymphocytes, Blood, 98, 3447, 10.1182/blood.V98.12.3447 Yu, 1994, Use of (CA)n polymorphisms to determine the origin of blood cells after allogeneic canine marrow grafting, Transplantation, 58, 701, 10.1097/00007890-199409270-00011 Hilgendorf, 2005, Canine haematopoietic chimerism analyses by semiquantitative fluorescence detection of variable number of tandem repeat polymorphism, Vet Res Commun, 29, 103, 10.1023/B:VERC.0000047486.01458.c5 Bindslev, 2006, Labelling of human mesenchymal stem cells with indium-111 for SPECT imaging: effect on cell proliferation and differentiation, Eur J Nucl Med Mol Imag, 33, 1171, 10.1007/s00259-006-0093-7 Keating, 2006, Mesenchymal stromal cells, Curr Opin Hematol, 13, 419, 10.1097/01.moh.0000245697.54887.6f Bernardo, 2009, Mesenchymal stromal cells, Ann NY Acad Sci, 1176, 101, 10.1111/j.1749-6632.2009.04607.x Aggarwal, 2005, Human mesenchymal stem cells modulate allogeneic immune cell responses, Blood, 105, 1815, 10.1182/blood-2004-04-1559 Meisel, 2004, Human bone marrow stromal cells inhibit allogeneic T cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation, Blood, 103, 4619, 10.1182/blood-2003-11-3909 Rasmusson, 2005, Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms, Exp Cell Res, 305, 33, 10.1016/j.yexcr.2004.12.013 Gao, 2001, The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion, Cells Tissues Organs, 169, 12, 10.1159/000047856 Chin, 2003, 111In oxine–labeled mesenchymal stem cell SPECT after intravenous administration in myocardial infarction, Nucl Med Commun, 24, 1149, 10.1097/00006231-200311000-00005